A real-world study of treatment patterns following disease progression in epithelial ovarian cancer patients undergoing poly-ADP-ribose polymerase inhibitor maintenance therapy

被引：0
作者：
Nan Zhang
Hong Zheng
Yunong Gao
Tong Shu
Hongguo Wang
Yan Cai
机构：
[1] Peking University Cancer Hospital and Institute,Gynecology Department, Key Laboratory of Carcinogenesis and Translational Research
[2] Ministry of Education of People’s Republic of China,undefined
来源：
Journal of Ovarian Research | / 17卷
关键词：
PARP; Epithelial ovarian cancer; BRCA; Maintenance therapy; Subsequent therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
[31]   Real-world applications of PARPi maintenance therapy for recurrent ovarian cancer: A single-center study in China [J].
Wang, Deng-Feng ;
Shi, Xun-Wei ;
Zhang, Can ;
Zhang, Jie ;
Liu, Hong ;
Huang, Jian-Ming ;
Zhang, Guo-Nan ;
Wen, Qing-Lian .
GYNECOLOGIC ONCOLOGY, 2023, 170 :25-31
[32]   A functional polymorphism in the poly(ADP-ribose) polymerase-1 gene is associated with platinum-based chemotherapeutic response and prognosis in epithelial ovarian cancer patients [J].
Zhao, Jian ;
Wu, Jianlei ;
Zuo, Weiwei ;
Kang, Shan ;
Li, Yan .
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2020, 255 :183-189
[33]   Real-World Maintenance Treatment Patterns Among Patients with Advanced Non-Small Cell Lung Cancer [J].
Shah, Manasee V. ;
Solem, Caitlyn T. ;
Bell, Kelly F. ;
Aziez, Amine ;
Sun, Xuezheng ;
Du, Mandy ;
Du, Ella X. ;
Yang, Hongbo ;
Wang, Hongjue ;
Hua, Qi ;
Tapan, Umit .
ADVANCES IN THERAPY, 2025, 42 (06) :2782-2796
[34]   Real-world efficacy and toxicity of olaparib maintenance therapy in Korean ovarian cancer patients with an exploratory analysis of BRCA mutations [J].
Kim, Junhwan ;
Park, So-Yeon ;
Kim, Ju-Hyun ;
Lee, Shin-Wha ;
Park, Jeong-Yeol ;
Kim, Jong-Hyeok ;
Kim, Yong-Man ;
Kim, Dae-Yeon .
GYNECOLOGIC ONCOLOGY, 2025, 194 :25-32
[35]   Antitumor activity of the poly(ADP-ribose) polymerase inhibitor rucaparib as monotherapy in patients with platinum-sensitive, relapsed, BRCA-mutated, high-grade ovarian cancer, and an update on safety [J].
Kristeleit, Rebecca S. ;
Oaknin, Ana ;
Ray-Coquard, Isabelle ;
Leary, Alexandra ;
Balmana, Judith ;
Drew, Yvette ;
Oza, Amit M. ;
Shapira-Frommer, Ronnie ;
Domchek, Susan M. ;
Cameron, Terri ;
Maloney, Lara ;
Goble, Sandra ;
Lorusso, Domenica ;
Ledermann, Jonathan A. ;
McNeish, Iain A. .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 (09) :1396-1404
[36]   ReOL - OLaparib in the REal World. A retrospective observational study to evaluate the impact of olaparib on the real-world treatment of BRCA carrier patients with recurrent ovarian cancer [J].
De Matteis, E. ;
Cormio, G. ;
Naglieri, E. ;
Scavelli, C. ;
Loizzi, V ;
Cito, P. ;
Chetri, M. C. ;
Tarantino, P. ;
Mazzoni, E. ;
Ronzino, G. .
EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2019, 40 (05) :759-764
[37]   Real world outcomes in platinum sensitive relapsed ovarian, fallopian tube, or peritoneal cancer treated in routine clinical practice in the United Kingdom prior to poly-ADP ribose polymerase inhibitors [J].
Lord, Rosemary ;
Rauniyar, Jyoti ;
Morris, Tamsin ;
Condon, Orlaith ;
Jones, Rachel ;
Miller, Rowan ;
Hall, Marcia ;
Lofts, Fiona ;
Glasspool, Rosalind M. ;
Hudson, Emma .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 (07) :1026-1033
[38]   Real-world outcomes of niraparib treatment in patients with ovarian cancer: a multicenter non-interventional study in China [J].
Li, Jin ;
Yang, Jianhua ;
Shou, Huafeng ;
Zhang, Lin ;
Huang, Xiaohong ;
Tang, Xuedong ;
Zheng, Fei ;
Liu, Fang ;
Wen, Hao ;
Yang, Huijuan ;
Wang, Huaying ;
Li, Ziting ;
Chen, Xiaojun ;
Ju, Xingzhu ;
Cheng, Xi ;
Tang, Jie ;
Zhang, Meiqin ;
Wu, Xiaohua .
CANCER COMMUNICATIONS, 2023, 43 (06) :716-719
[39]   Endocrine Maintenance Therapy in High-Grade Serous Ovarian Cancer: A Retrospective Off-Label Real-World Cohort Study [J].
Geissler, Franziska ;
Graf, Flurina ;
Zwimpfer, Tibor A. ;
Eller, Ruth S. ;
Nguyen-Strauli, Bich Doan ;
Schotzau, Andreas ;
Heinzelmann-Schwarz, Viola ;
Gobrecht-Keller, Ursula .
CANCERS, 2025, 17 (08)
[40]   Expert Consensus Recommendations on the Management of Treatment-emergent Adverse Events Among Men with Prostate Cancer Taking Poly-ADP Ribose Polymerase Inhibitor plus Novel Hormonal Therapy Combination Therapy [J].
Shore, Neal D. ;
Broder, Michael S. ;
Barata, Pedro C. ;
Crispino, Tony ;
Fay, Andre P. ;
Lloyd, Jennifer ;
Mellado, Begona ;
Matsubara, Nobuaki ;
Pfanzelter, Nicklas ;
Schlack, Katrin ;
Sieber, Paul ;
Soares, Andrey ;
Dalglish, Hannah ;
Niyazov, Alexander ;
Shaman, Saif ;
Zielinski, Michael A. ;
Chang, Jane ;
Agarwal, Neeraj .
EUROPEAN UROLOGY ONCOLOGY, 2025, 8 (01) :94-104
12345